Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Sirolimus × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Hematologic Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Melanoma 1 Medulloblastoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphangioleiomyomatosis 1

Interventions

pembrolizumab 16 enfortumab vedotin 12 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 atezolizumab 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡